Your Cart ( 1 Item )

• Imiquimod 2.5% and 3.75% for the Treatment of Actinic Keratoses: Two Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies
  November 2013 | Volume 12 | Issue 11 | Original Article | 1278 | Copyright © November 2013
  Neil Swanson MD^a, Christina Cognata Smith MD^b, Mandeep Kaur MD^b, and Gary Goldenberg M^c
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs